Hide
Show all
Email this article Could vitamin D reduce the risk of COVID-19?
Abstract
In December, 2019, several cases of pneumonia of unknown cause was identified in Wuhan City, Hubei Province of China. Further analysis revealed the reason of an outbreak – a novel β coronavirus which was named as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that causes coronavirus disease 2019 - COVID-19. The outbreak of novel coronavirus has spread rapidly worldwide. At the same time, scientists started working hard to create a medicine and a vaccine. However, there is still no specific drug for COVID-19 now. In this situation, before creating specific treatment and vaccine, it is especially important to find some therapeutic option that may have a positive effect in the prevention or treatment of the disease. We have reviewed the literature on the possible link between vitamin D and COVID-19.
Keywords
Full Text:
PDFReferences
WHO. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
Wang LS, Wang YR, Ye DW, Liu QQ. A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence. International Journal of Antimicrobial Agents. 2020 Mar 19:105948.
Uddin M, Mustafa F, Rizvi TA, Loney T, Al Suwaidi H, Al Marzouqi A, Eldin AK, Alsabeeha N, Adrian TE, Stefanini C, Nowotny N. SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions.
Jahangir MA, Muheem A, Rizvi MF. Coronavirus (COVID-19): History, Current Knowledge and Pipeline Medications. Int J Pharm Pharmacol 2020; 4: 140. doi: 10.31531/2581.;3080(2).
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020 Feb 15;395(10223):497-506..
Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery. 2020 Feb 26.
Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. Journal of Clinical Virology. 2011 Mar 1;50(3):194-200.
Unal AD, Tarcin O, Parildar H, Cigerli O, Eroglu H, Demirag NG. Vitamin D deficiency is related to thyroid antibodies in autoimmune thyroiditis. Central-European journal of immunology. 2014;39(4):493.
Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. The Journal of Immunology. 2008 Nov 15;181(10):7090-9.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020 Apr;12(4):988.
Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert opinion on biological therapy. 2007 Sep 1;7(9):1449-61.
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. bmj. 2017 Feb 15;356:i6583.
Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. The American journal of clinical nutrition. 2010 May 1;91(5):1255-60.
Sigmund CD. Regulation of renin expression and blood pressure by vitamin D 3. The Journal of clinical investigation. 2002 Jul 15;110(2):155-6.
Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin–angiotensin system and blood pressure. The Journal of steroid biochemistry and molecular biology. 2004 May 1;89:387-92.
Xu J, Yang J, Chen J, Luo Q, Zhang Q, Zhang H. Vitamin D alleviates lipopolysaccharide induced acute lung injury via regulation of the renin angiotensin system. Molecular medicine reports. 2017 Nov 1;16(5):7432-8.
Backer A. Slower COVID-19 Case and Death Count Growth at Higher Irradiances and Temperatures. Available at SSRN 3567587. 2020 Apr 2.
Anis A. The Effect of Temperature Upon Transmission of COVID-19: Australia And Egypt Case Study. Available at SSRN 3567639. 2020 Apr 2.
Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of COVID-19 progression. Médecine et Maladies Infectieuses. 2020 Apr 4.
Rostkowska-Nadolska B, Sliupkas-Dyrda E, Potyka J, Kusmierz D, Fraczek M, Krecicki T, Kubik P, Zatonski M, Latocha M. Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. Advances in medical sciences. 2010 Jan 1;55(1):86-92.
Wimalawansa SJ. COVID-19 might be fought by 2 doses of Vitamin D (200,000-300,000 IU each)–Feb 2020. European Journal of Biomedical and Pharmaceutical Sciences. 2020;7(3):432-8.
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systemic review. Journal of medical virology. 2020 Feb 13.
Refbacks
- There are currently no refbacks.
ISSN: 2346-8491 (online)